Disc Medicine Presents Positive Updated Results From Phase 1B Trial In Patients With Myelofibrosis (MF) And Anemia In An Oral Presentation At The 66Th American Society Of Hematology (ASH) Annual Meeting
Disc Medicine Presents Positive Updated Results From Phase 1B Trial In Patients With Myelofibrosis (MF) And Anemia In An Oral Presentation At The 66Th American Society Of Hematology (ASH) Annual Meeting . (MENAFN - GlobeNewsWire - Nasdaq)    Demonstrated durable hematologic response across all patient subgroups, regardless of baseline transfusion status and concomitant JAK inhibitor therapy   Phase 2 ...
América - MenaFN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108969241/Disc-Medicine-Presents-Positive-Updated-Results-From-Phase-1B-Trial-In-Patients-With-Myelofibrosis-MF-And-Anemia-In-An-Oral-Presentation-At-The-66Th-American-Society-Of-Hematology-ASH-Annual-Meeting
2024-12-08
rss
(MENAFN - GlobeNewsWire - Nasdaq)    Demonstrated durable hematologic response across all patient subgroups, regardless of baseline transfusion status and concomitant JAK inhibitor therapy   Phase 2 ...
Disc Medicine Presents Positive Updated Results From Phase 1B Trial In Patients With Myelofibrosis (MF) And Anemia In An Oral Presentation At The 66Th American Society Of Hematology (ASH) Annual Meeting